AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6123635 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal-based electrolyte solution (30 g rice powder per litre)
Number of subjects: 124
Study 6123635 — intervention group
Group type: COMPARATOR
Intervention: Standard sucrose‐electrolyte solution
Number of subjects: 124
Study 31559916 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit racial discrimination
Number of subjects: 198
Study 31559916 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit racial discrimination
Number of subjects: 198
Study 31559916 — intervention group
Group type: COMPARATOR
Intervention: No discrimination control
Number of subjects: 198
Study 28385937 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal infiltration with posterior capsular infiltration (PCI)
Number of subjects: 86
Study 28385937 — intervention group
Group type: COMPARATOR
Intervention: Multimodal infiltration without posterior capsular infiltration (PCI)
Number of subjects: 86
Study 24521459 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated individual dietary counselling by a nutritionist during and after pregnancy
Number of subjects: 256
Study 24521459 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary counselling)
Number of subjects: 256
Study 24521459 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated individual dietary counselling
Number of subjects: 256
Study 24273453 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam plus Ondansetron (Group O)
Number of subjects: 230
Study 24273453 — intervention group
Group type: COMPARATOR
Intervention: Nefopam alone (Group N)
Number of subjects: 230
Study 21779086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145
Study 21779086 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145
Study 19411363 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention training
Number of subjects: 56
Study 17572321 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB) (n = 12)
Number of subjects: 22
Study 17572321 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI) (n = 10)
Number of subjects: 22
Study 17572321 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB)
Number of subjects: 22
Study 17572321 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI)
Number of subjects: 22
Study 14961886 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient hysteroscopy
Number of subjects: 97
Study 14961886 — intervention group
Group type: COMPARATOR
Intervention: Daycase hysteroscopy
Number of subjects: 97
Study 10961474 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg acetylsalicylic acid (ASA)
Number of subjects: 53
Study 10961474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 9135811 — intervention group
Group type: EXPERIMENTAL
Intervention: Two different target types
Number of subjects: 7
Study 1544078 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician reminder group
Number of subjects: 5242
Study 1544078 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder group
Number of subjects: 5242
Study 1544078 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter reminder group
Number of subjects: 5242
Study 1544078 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5242
Study 3839446 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg ciramadol
Number of subjects: 0
Study 3839446 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ciramadol
Number of subjects: 0
Study 3839446 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ciramadol
Number of subjects: 0
Study 3839446 — intervention group
Group type: COMPARATOR
Intervention: 325 mg aspirin
Number of subjects: 0
Study 3839446 — intervention group
Group type: COMPARATOR
Intervention: 650 mg aspirin
Number of subjects: 0
Study 3839446 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear and curvilinear pain analog intensity scales
Number of subjects: 0
Study 2885928 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg at night
Number of subjects: 132
Study 2885928 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg at night
Number of subjects: 132
Study 2885928 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 132
Study 29755474 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (SLE-TR, n=9)
Number of subjects: 19
Study 25796150 — intervention group
Group type: EXPERIMENTAL
Intervention: Huayu Zhitong powder
Number of subjects: 200
Study 25796150 — intervention group
Group type: COMPARATOR
Intervention: Traditional Shangke Jiegu tablets
Number of subjects: 200
Study 23650000 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with relapsing-remitting multiple sclerosis (MS)
Number of subjects: 30
Study 23650000 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with advanced stage MS (duration of 5-6 years)
Number of subjects: 30
Study 23650000 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with advanced stage MS
Number of subjects: 30
Study 23650000 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 individuals)
Number of subjects: 30
Study 20739691 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization self‐exercise treatment
Number of subjects: 52
Study 20739691 — intervention group
Group type: COMPARATOR
Intervention: Occlusal splints
Number of subjects: 52
Study 18259011 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 863
Study 18259011 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 863
Study 16701922 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched milk (500 cm³ per day) with 5.7 g of oleic acid, 0.2 g of omega-3 fatty acid, 150 µg of folic acid, and 7.5 mg of vitamin E
Number of subjects: 72
Study 16701922 — intervention group
Group type: COMPARATOR
Intervention: Control group (500 cm³ semi-skimmed milk per day)
Number of subjects: 72
Study 12673463 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of pure natural honey (20 ml before, after, and 6 hours post-radiation therapy)
Number of subjects: 40
Study 12673463 — intervention group
Group type: COMPARATOR
Intervention: Control group (radiation alone)
Number of subjects: 40
Study 12673463 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of pure natural honey
Number of subjects: 40
Study 10718162 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial motivation (CMR scores)
Number of subjects: 0
Study 9184260 — intervention group
Group type: EXPERIMENTAL
Intervention: M-CSF expression in periprosthetic tissues (interface and pseudocapsule)
Number of subjects: 20
Study 9184260 — intervention group
Group type: COMPARATOR
Intervention: Synovial tissue from patients with primary THR for osteoarthritis
Number of subjects: 20
Study 1603402 — intervention group
Group type: EXPERIMENTAL
Intervention: XYLIHEX
Number of subjects: 45
Study 1603402 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX
Number of subjects: 45
Study 1603402 — intervention group
Group type: COMPARATOR
Intervention: F
Number of subjects: 45
Study 2580172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg) while fasting
Number of subjects: 25
Study 2580172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after eating
Number of subjects: 25
Study 2580172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice a day for 3-12 months) taken 1 h before eating
Number of subjects: 25
Study 2580172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice a day for 3-12 months) taken during or immediately after eating
Number of subjects: 25
Study 2580172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31775406 — intervention group
Group type: EXPERIMENTAL
Intervention: C-arm guided percutaneous RF ablation
Number of subjects: 80
Study 31775406 — intervention group
Group type: COMPARATOR
Intervention: Local intradermal BTX-A injection
Number of subjects: 80
Study 29049149 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified nasal septal chain suture technique
Number of subjects: 40
Study 29049149 — intervention group
Group type: COMPARATOR
Intervention: Previous nasal septal chain suture technique
Number of subjects: 40
Study 26658447 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (>140 mg/dL)
Number of subjects: 0
Study 26658447 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemia (≤140 mg/dL)
Number of subjects: 0
Study 26658447 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher glucose levels (per 10 mg/dL increase) in patients with incomplete reperfusion
Number of subjects: 0
Study 26658447 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete reperfusion
Number of subjects: 0
Study 25398084 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized DNA-based dietary advice for 12 months
Number of subjects: 138
Study 25398084 — intervention group
Group type: COMPARATOR
Intervention: General dietary recommendations with no genetic information for 12 months
Number of subjects: 138
Study 25398084 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized DNA-based dietary advice for 12 months (for those with risk version of ACE gene)
Number of subjects: 138
Study 24321171 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training program based on the mhGAP intervention guide
Number of subjects: 86
Study 24321171 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 86
Study 20229136 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 13
Study 20229136 — intervention group
Group type: COMPARATOR
Intervention: Standard TKA
Number of subjects: 13
Study 17988643 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam (Oculus, Inc, Wetzlar, Germany)
Number of subjects: 53
Study 17988643 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound pachymetry
Number of subjects: 53
Study 17988643 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference between Pentacam and ultrasound
Number of subjects: 53
Study 16644277 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS with low-plasma valproate levels
Number of subjects: 15
Study 16644277 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS with high-plasma valproate levels
Number of subjects: 15
Study 16644277 — intervention group
Group type: COMPARATOR
Intervention: 1 Hz rTMS in healthy subjects
Number of subjects: 15
Study 16644277 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between plasma valproate levels and motor threshold changes after 1 Hz rTMS
Number of subjects: 15
Study 15055412 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 consecutive synthetic polyester fiber (Dacron) swabs
Number of subjects: 103
Study 15055412 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Dacron swab
Number of subjects: 103
Study 15055412 — intervention group
Group type: EXPERIMENTAL
Intervention: Tampon
Number of subjects: 103
Study 15055412 — intervention group
Group type: COMPARATOR
Intervention: Clinician-directed sampling of the ectocervix and endocervix
Number of subjects: 103
Study 10838252 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretching combined with the use of night splints (group A)
Number of subjects: 27
Study 10838252 — intervention group
Group type: COMPARATOR
Intervention: Passive stretching (group B)
Number of subjects: 27
Study 9235005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg atracurium
Number of subjects: 45
Study 9235005 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075 mg/kg atracurium
Number of subjects: 45
Study 9235005 — intervention group
Group type: COMPARATOR
Intervention: 0.0125 mg/kg pancuronium followed by 0.45 mg/kg atracurium
Number of subjects: 45
Study 1540804 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex Doppler ultrasound measuring resistive index (RI)
Number of subjects: 0
Study 1540804 — intervention group
Group type: COMPARATOR
Intervention: Control group (children with normal renal function)
Number of subjects: 0
Study 2434759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 7
Study 2434759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 7
Study 2434759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 29054329 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the primary motor area (M1)
Number of subjects: 0
Study 29054329 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the supplementary motor area (SMA)
Number of subjects: 0
Study 29054329 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study 29054329 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 29054329 — intervention group
Group type: EXPERIMENTAL
Intervention: All stimulation targets (M1, SMA, DLPFC)
Number of subjects: 0
Study 27413070 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant fusion protein ESAT6-CFP10 (1, 5, 10, or 20 μg/ml)
Number of subjects: 24
Study 25715786 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 0
Study 25715786 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous local anaesthetic infusion via wound infusion catheter (WIC)
Number of subjects: 0
Study 25715786 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 23810678 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (standard induction and maintenance schedule)
Number of subjects: 22
Study 23810678 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (2.5 mg/kg/day)
Number of subjects: 22
Study 20863236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG (1.0 W, 10 Hz, 20 sec) for dentinal tubules sealing
Number of subjects: 50
Study 20863236 — intervention group
Group type: EXPERIMENTAL
Intervention: Root-end cavity without Nd:YAG
Number of subjects: 50
Study 20863236 — intervention group
Group type: EXPERIMENTAL
Intervention: Root-end cavity and Nd:YAG application
Number of subjects: 50
Study 20863236 — intervention group
Group type: EXPERIMENTAL
Intervention: Root-end cavity made by Er:YAG with no focus and without Nd:YAG application
Number of subjects: 50
Study 20863236 — intervention group
Group type: EXPERIMENTAL
Intervention: Without root-end cavity and without Nd:YAG application
Number of subjects: 50
Study 17962512 — intervention group
Group type: EXPERIMENTAL
Intervention: MIPI (MCL international prognostic index)
Number of subjects: 455
Study 17962512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell proliferation (Ki-67)
Number of subjects: 455
Study 17962512 — intervention group
Group type: COMPARATOR
Intervention: IPI and FLIPI
Number of subjects: 455
Study 16155739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management (ICM)
Number of subjects: 0
Study 12852708 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 5133
Study 12852708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5133
Study 10377209 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg)
Number of subjects: 11
Study 10377209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8984865 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 0
Study 8984865 — intervention group
Group type: COMPARATOR
Intervention: Reinforced laryngeal mask airway
Number of subjects: 0
Study 8984865 — intervention group
Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 0
Study 8984865 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of mask aperture bars
Number of subjects: 0
Study 1658321 — intervention group
Group type: EXPERIMENTAL
Intervention: Menstrual pads containing sodium bicarbonate
Number of subjects: 50
Study 1658321 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate alone
Number of subjects: 50
Study 6161689 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAB chemotherapy (streptozocin, lomustine, doxorubicin hydrochloride, and bleomycin sulfate)
Number of subjects: 20
Study 6161689 — intervention group
Group type: COMPARATOR
Intervention: SCAB chemotherapy
Number of subjects: 20
Study 30117052 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 25
Study 30117052 — intervention group
Group type: COMPARATOR
Intervention: Long pulse Nd:YAG laser
Number of subjects: 25
Study 28833562 — intervention group
Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg once daily at bedtime for 13 weeks
Number of subjects: 75
Study 28833562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 28833562 — intervention group
Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg
Number of subjects: 75
Study 26237305 — intervention group
Group type: EXPERIMENTAL
Intervention: Water preloading (500 ml of water 30 min before meals)
Number of subjects: 84
Study 26237305 — intervention group
Group type: COMPARATOR
Intervention: Attention control (imagining stomach full before meals)
Number of subjects: 84
Study 23319439 — intervention group
Group type: COMPARATOR
Intervention: Green Tea (GT)
Number of subjects: 0
Study 23319439 — intervention group
Group type: COMPARATOR
Intervention: Black Tea (BT)
Number of subjects: 0
Study 23319439 — intervention group
Group type: COMPARATOR
Intervention: Green Tea (GT) and Black Tea (BT)
Number of subjects: 0
Study 23319439 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4-DHPAA and EGCG (in vitro treatment)
Number of subjects: 0
Study 23319439 — intervention group
Group type: EXPERIMENTAL
Intervention: 3OMGA
Number of subjects: 0
Study 21471566 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (1 g in 500 ml of 0.9% saline intravenously over 4 h, n=16)
Number of subjects: 24
Study 21471566 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline, n=8)
Number of subjects: 24
Study 19494025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO)
Number of subjects: 64
Study 19494025 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (OO)
Number of subjects: 64
Study 19494025 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid (LA)
Number of subjects: 64
Study 16424644 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week VACOP-B followed by high-dose sequential chemotherapy (HDS) and autologous stem cell transplantation (ASCT)
Number of subjects: 56
Study 16424644 — intervention group
Group type: COMPARATOR
Intervention: 12-week VACOP-B
Number of subjects: 56
Study 14697077 — intervention group
Group type: EXPERIMENTAL
Intervention: Wave-line technique
Number of subjects: 24
Study 14697077 — intervention group
Group type: COMPARATOR
Intervention: Classic intravelar veloplasty
Number of subjects: 24
Study 11402280 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs and physical therapy
Number of subjects: 60
Study 11402280 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive individuals
Number of subjects: 12501
Study 9143613 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative individuals
Number of subjects: 12501
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adult deaths
Number of subjects: 12501
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults aged 20-29 years
Number of subjects: 12501
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive deaths
Number of subjects: 12501
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDS-related deaths
Number of subjects: 12501
Study 9143613 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of HIV-related deaths
Number of subjects: 12501
Study 8565795 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with opioid receptor antagonists naltrexone and nalmefene
Number of subjects: 0
Study 2233917 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (40 mg of prednisone twice daily)
Number of subjects: 333
Study 2233917 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (Control)
Number of subjects: 333
Study 652481 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at eleven azimuth positions (experiment 1)
Number of subjects: 0
Study 652481 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at ten angles of elevation (experiment 4)
Number of subjects: 0
Study 652481 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven vertical lines presented at a single azimuth position before another (experiment 3)
Number of subjects: 0
Study 652481 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven vertical lines permutated randomly in experiments 1 and 2
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney-sparing surgery for low-grade UTUC
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical nephroureterectomy with bladder cuff excision
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative bladder instillation of chemotherapy
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteroscopic management of low-grade and non-invasive UTUC
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphadenectomy
Number of subjects: 0
Study 31123852 — intervention group
Group type: EXPERIMENTAL
Intervention: Platin-based chemotherapy for invasive UTUC
Number of subjects: 0
Study 31123852 — intervention group
Group type: COMPARATOR
Intervention: Bacillus Calmette-Guérin (BCG) and mitomycin C
Number of subjects: 0
Study 28394302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative enteral nutrition (pre-EN) through a nasal-jejunum feeding tube
Number of subjects: 68
Study 28394302 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (PN)
Number of subjects: 68
Study 25757214 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial immune function testing (ImmuKnow assay)
Number of subjects: 202